Quell will no longer be available without a prescription after September 30. Quell Update Notice

How Does Quell Relieve Pain?

Quell uses transcutaneous electrical nerve stimulation (TENS) to stimulate sensory nerves in your leg with safe, painless, and precise electrical impulses to trigger a natural pain relief response. TENS devices like Quell have been used by physicians, physical therapists, and other health care professions for decades to manage pain.

Learn How TENS Works

Over 20 Years of Research

The company was started by Dr. Shai Gozani, M.D., Ph.D., while conducting research at MIT. NeuroMetrix has spent over 20 years developing technology to help physicians diagnose nerve disorders and, more recently, to address chronic pain.

With over 70 patents awarded since 1996, Quell is the product of this expertise and combines neurostimulation and digital health technologies to relieve chronic pain.

Quell is the most technologically advanced TENS device

Smart Technology

Quell is pain relief technology that can live with you day and night. It is smart enough to adjust therapy while you sleep and even to compensate for changes in the weather. With the Quell smartphone app, you can track your progress, including pain levels, activity, gait, sleep and mood.  You can even control Quell from your Apple Watch.

Learn More

Quell Designed for People

Advanced Neurotechnology

  • Not much bigger than a credit card, and comfortable enough to use 24/7
  • Powered by an advanced neurostimulation microchip
  • Sophisticated algorithms automatically control and personalize nerve stimulation (Learn more)
  • Bluetooth low energy (BLE) to communicate with your smartphone and smartwatch
  • Novel battery technology only requires recharging once or twice a week (Learn more)
  • Covered by 15 US utility patents

For Best Results, Use Daily

We recommend using Quell for at least three 1-hour therapy sessions per day.  The more you use Quell, the better chance you have of experiencing pain relief. (Learn more)

Sign me up for the latest news on Quell